Question 1

What is the share price of Eris Lifesciences Limited today?

Accepted Answer

Eris Lifesciences Limited (ERIS) is trading at ₹1,177.7. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is ERIS’s P/E ratio versus the sector?

Accepted Answer

ERIS trades at a P/E of 77.3. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is ERIS’s dividend yield?

Accepted Answer

ERIS has a dividend yield of 0.63%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is ERIS’s 52-week high and low?

Accepted Answer

ERIS has traded between ₹1,069 and ₹1,740 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Eris Lifesciences Limited?

Accepted Answer

Eris Lifesciences Limited has a market capitalisation of ₹15,949 crore.

Question 6

What is ERIS’s return on equity?

Accepted Answer

ERIS reports a return on equity of 8.9%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are ERIS’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is ERIS’s promoter holding?

Accepted Answer

Promoters hold 54.14% of ERIS. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include ERIS?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight ERIS carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Eris Lifesciences Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from ERIS’s own numbers. The judgement is yours.

ERIS

ERIS

Value & Investment Index

VII Detail

Multiples vs Peers

Quality Scores

Versus Its Own History

Scenario analysis

ERIS valuation summary

P/E	77.3
ROE	8.9%
ROCE	11.0%
Dividend yield	0.63%